Share First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial

Share First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial / Testa, L; Et, Al. - In: EUROINTERVENTION. - ISSN 1774-024X. - 16:2(2021), pp. E133-E140. [10.4244/eij-d-19-00600]